NPLEx Brings A ‘Quiet’ Year On State PSE Legislation – CHPA
This article was originally published in The Tan Sheet
CHPA President and CEO Scott Melville says 2015 is the “quietest” in five years for state legislation on the sale of pseudoephedrine, a testament to NPLEx. Bills for Rx-only PSE sales introduced in four states this year failed.
You may also be interested in...
Former Mississippi Gov. Haley Barbour says industry should ask state legislators to repeal the 2010 law that made all PSE drugs Rx-only. CHPA “might get some listeners” if it highlights how the tracking system places less of a financial burden on consumers and the health care system, he says.
FDA asks two Mexican manufacturers for batch and supplier data on the products found to contain mostly methanol instead of ethanol. Its The FDA’s recall records still are frequently updated with announcements of additional recalls of OTC sanitizers due to the presence of methanol.
Anytime COVID Test marketed home-use test without FDA approval or EUA and promoted it with an FDA logo and a “clinical trial number.” Warning letter says “your presentation conveys the misimpression that the product has been approved, cleared, authorized, endorsed or otherwise evaluated by FDA.”